GenMark Diagnostics Profit Margin

GenMark Diagnostics (GNMK) currently reports a profit margin of -10.87% as of December 2020. That compares with -53.79% in the prior-year period — up 79.8% year over year. That is below the Healthcare sector average of 13.76%. Use the charts on this page to explore GenMark Diagnostics's profit margin history and peer comparisons.

GenMark Diagnostics's profit margin increased from -53.79% to -10.87% — a 79.8% year-over-year increase (period ending December 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GenMark Diagnostics's profit margin of -10.87% is lower than the Healthcare sector average of 13.76%. That is roughly 179.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but GenMark Diagnostics's current -10.87% should be judged against Healthcare norms (sector average: 13.76%) and against GNMK's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -10.87%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.76%. From there, open related valuation or income-statement pages for GenMark Diagnostics, and consider following GNMK for alerts when major investors trade the stock.